Medical Hypotheses
Volume 56, Issue 2 , Pages 181-193 , February 2001

Can melatonin regulate the expression of prohormone convertase 1 and 2 genes via monomeric and dimeric forms of RZR/ROR nuclear receptor, and can melatonin influence the processes of embryogenesis or carcinogenesis by disturbing the proportion of cAMP and cGMP concentrations? Theoretic model of controlled apoptosis

Received 15 September 1999 ,Accepted 3 April 2000.

References 

    REFERENCES
  1. Mangelsdorf DJ, Thummel C, Beato HM, Herrlich P, Schutz G, Umesono K, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835–839
  2. Green, S. Nuclear hormone receptors. Promiscuous liaisons [news; comment]. Nature, 361, 590, 591.
  3. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991;65:1255–1266
  4. Carlberg C. Mechanisms of nuclear signalling by vitamin D3. Interplay with retinoid and thyroid hormone signalling. Eur J Biochem. 1995;231:517–527
  5. Chen F, Cooney AJ, Wang Y, Law SW, O’Malley BW. Cloning of a novel orphan receptor (GCNF) expressed during germ cell development. Mol Endocrinol. 1994;8:1434–1444
  6. Dreyer C, Keller H, Mahfoudi A, Laudet V, Krey G, Wahli W. Positive regulation of the peroxisomal beta-oxidation pathway by fatty acids through activation of the peroxisome proliferator-activated receptor (PPAR). Biol Cell. 1993;77:67–76
  7. Laudet V, Hanni C, Coll J, Catzeflis F, Stehelin D. Evolution of the nuclear receptor gene superfamily. EMBO J,. 1992;11:1003–1013
  8. Zhang XK, Lehmann J, Hoffmann B, Dawson MI, Cameron J, Graupner G, et al. Homodimer formation of retinoid X receptor induced by 9-cis retinoic acid. Nature. 1992;358:587–591
  9. Green S, Chambon P. Nuclear receptors enhance our understanding of transcription regulation. Trends Genet. 1988;4:309–314
  10. Leid M, Kastner P, Chambon P. Multiplicity generates diversity in the retinoic acid signalling pathways. Trends Biochem. 1992;17:427–433
  11. Glass CK. Differential recognition of target genes by nuclear receptor monomers, dimers, and heterodimers. Endocr Rev. 1994;15:757–770
  12. Carlberg C, Hooft van Huijsduijnen R, Staple JK, DeLamarter JF, Becker-Andre M. RZRs, a new family of retinoid- related orphan receptors that function as both monomers and homodimers. Mol Endocrinol. 1994;8:757–770
  13. Schrader M, Becker-Andre M, Carlberg C. Thyroid hormone receptor functions as monomeric ligand-induced transcription factor on octameric half-sites. Consequences also for dimerization. J Biol Chem. 1994;269:6444–6449
  14. Becker-Andre M, Wiesenberg I, Schaeren-Wiemers N, Andre E, Missbach M, Saurat JH, et al. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem. 1994;269:28531–28534
  15. Steinhilber D, Brungs M, Werz O, Wiesenberg I, Danielsson C, Kahlen JP, et al. The nuclear receptor for melatonin represses 5-lipoxygenase gene expression in human B lymphocytes. J Biol Chem. 1995;270:7037–7040
  16. Carlberg C, Wiesenberg I. The orphan receptor family RZR/ROR, melatonin and 5-lipoxygenase: an unexpected relationship. J Pineal Res. 1995;18:171–178
  17. Wiesenberg I, Missbach M, Kahlen JP, Schrader M. Transcriptional activation of the nuclear receptor RZR alpha by the pineal gland hormone melatonin and identification of CGP 52608 as a synthetic ligand. Nucleic Acids Res. 1995;23:327–333
  18. Becker-Andre M, Schraen-Wiemers N, Andre E. Additions and corrections. vol.269 (1994) 28531–34. Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily. J Biol Chem. 1997;16:707
  19. Ciesla W. Can high maternal melatonin concentrations be responsible for inducing fetal pathologies, and can melatonin participate in immuno-hormonal homeostasis by determining prohormone convertase activity?. Hypothesis and facts. Med Hypotheses. 1998;51:269–280
  20. Bertagna X. Proopiomelanocortin-derived peptides. Endocrinol Metab Clin North Am. 1994;23:467–485
  21. Vieau D, Seidah NG, Mbikay M, Chretien M, Bertagna X. Expression of the prohormone convertase PC2 correlates with the presence of corticotropin-like intermediate lobe peptide in human adrenocorticotropin-secreting tumors. J Clin Endocrinol Metab. 1994;79:1503–1506
  22. Marcinkiewicz M, Day R, Seidah NG, Chrietien M. Ontogeny of the prohormone convertases PC1 and PC2 in the mouse hypophysis and their colocalization with corticotropin and αmelanotropin. Proc Natl Acad Sci USA. 1993;90:4922–4926
  23. Day R, Schafer MK, Watson SJ, Chretien M, Seidah NG. Distribution and regulation of the prohormone convertases PC1 and PC2 in the rat pituitary. Mol Endocrinol. 1992;6:485–497
  24. Silman RE, Chard T, Lowry PJ, Smith I, Young IM. Human foetal pituitary peptides and parturition. Nature. 1976;260:716–718
  25. Silman RE, Street C, Holland D, Chard T, Falconer J, Robinson JS. The pars intermedia and the fetal pituitary-adrenal axis. Ciba Found Symp. 1981;81:180–195
  26. Munoz-Hoyos A, Rodriguez-Cabezas T, Molina-Caballo A, Martinez-Sempere JJ, Ruiz-Cosano C, Acuna-Castroviejo D. Melatonin concentration in the umbilical artery and vein in human preterm and term neonates and neonates with acute fetal distress. J Pineal Res. 1992;13:184–191
  27. Thakkar JK, Sperelakis N. Changes in cyclic nucleotid levels during embryonic development of chick hearts. J Dev Physiol. 1987;9:497–505
  28. Moriyama Y, Hasegawa S, Murayama K. cAMP and cGMP changes associated with the differentiation of cultured chick embryo muscle cells. Exp Cell Res. 1976;101:159–163
  29. Friedman DL. Role of cyclic nucleotides in cell growth and differentiation. Physiol Rev. 1976;56:652–708
  30. Cote M, Payet MD, Gallo-Payet N. Association of alpha S-subunit of the GS protein with microfilaments and microtubules: implication during adrenocorticotropin stimulation in adrenal glomerulosa cells. Endocrinology. 1997;138:69–78
  31. Williams JA, Greenspan FS. Mechanism of hormone secretion and action. Basic and Clinical Endocrinology. San Francisco, CA: Appleton and Lange; 1991; p. 1–20.
  32. Tamai KT, Monaco L, Nantel F, Zazopoulos E, Sassone-Corsai P. Coupling signalling pathways to transcriptional control: nuclear responsive to cAMP. Recent Prog Horm Res. 1997;52:121–140
  33. Sassone-Corsi P. Coupling gene expression to cAMP signalling: role of CREB and CREM. Int J Biochem Cell Biol. 1998;30:27–38
  34. Diaz-Lopez B, Martin-Fernandez B. Effects of melatonin administration to rats upon different parametrs of the offspring. Reproduction. 1983;7:1–7
  35. Lewinski A, Szymczykiewicz P, Sewerynek E, Wajs E. Effects of pinealectomy and melatonin administration on certain indices of ovarian hyperplasia and or hypertrophy in rats with both ovaries intact or after unilateral ovariectomy. J Pineal Res. 1993;14:117–127
  36. Horton TH, Ray SL, Rollag MD, Yellon SM, Stetson MH. Maternal transfer of photoperiodic information in Siberian hamsters. Effects of melatonin implants are dependent on photoperiod. Biol Reprod. 1992;47:291–296
  37. Weaver DR, Keohan JT, Reppert SM. Definition of a prenatal sensitive period for maternal-fetal communication of day length. Am J Physiol. 1987;253:E701–E704
  38. Glass JD, Dolan PL. Melatonin acts in the brain to mediate seasonal steroid inhibition of luteinizing hormone secretion in the white-footed mouse ( Peromyscus leucopus ). Proc Soc Exp Biol Med. 1988;188:375–380
  39. Carlson LL, Weaver DR, Reppert SM. Melatonin receptors and signal transduction during development in Siberian hamsters ( Phodopus sungorus ). Brain Res Dev Brain Res. 1991;39:83–88
  40. Ciesla W. Low ACTH and high melatonin concentrations in amniotic fluid as a hormonal markers of high risk of fetal abnormalities occurence. Preliminary studies. Prenatal Diag. 1998;18:980–983
  41. Nir I, Hirschmann N, Puder M, Petrank J. Changes in rodent thyroid hormones and cyclic-AMP following treatment with pineal indolic compounds. Arch Int Physiol Biochim. 1978;86:353–362
  42. Weiss B. On the regulation of adenyl cyclase activity in the rat pineal gland. Ann NY Acad Sci. 1971;185:507–519
  43. Zatz M. Does the circadian pacemaker act through cyclic AMP to drive the melatonin rhythm in chick pineal cells?. J Biol Rhythms. 1992;7:301–311
  44. Greene RM, Lloyd MR, Uberti M, Nugent P, Pisano MM. Patterns of cyclic AMP-dependent protein kinase gene expression during ontogeny of the murine palate. J Cell Physiol. 1995;163:431–440
  45. Greene RM, Lloyd MR, Pisano MM. Cyclic AMP-dependent protein kinase in human embryonic palate mesenchymal cells. In Vitro Cell Dev Biol. 1992;28A:755–762
  46. Linask KK, Greene RM. Ontogenetic analysis of embryonal palatal type I and type II cAMP-dependent protein kinase isozymes. Cell Differ Dev. 1989;28:189–202
  47. Tash JS, Means AR. Regulation of protein phosphorylation and motility of sperm by cyclic adenosine monophosphate and calcium. Biol Reprod. 1982;26:745–763
  48. Dedman JR. Regulation of microfilaments and microtubules by calcium and cyclic AMP. Adv Cyclic Nucleotide Res. 1979;11:131–174
  49. Sandoval IV, Cuatrecasas P. Protein kinase associated with tubulin: affinity chromatography and properties. Biochemistry. 1976;15:3424–3432
  50. Choi SY, Kim KT. Extracellular ATP-stimulated increase of cytosolic cAMP in HL-60 cells. Biochem Pharmacol. 1997;53:429–432
  51. Schiffmann Y. Bistability and control for ATP synthase and adenylate cyclase is obtained by removal of substrate inhibition. Mol Cell Biochem. 1989;86:19–40
  52. Pariente F, Prasad V, Luduena RF, Manso-Martinez R. Effects of ATP and cyclic AMP on the in vitro assembly and stability of mammalian brain microtubules. Mol Cell Biochem. 1987;474:43–54
  53. White DR, Aitken RJ. Relationship between calcium, cyclic AMP, ATP, and intracellular pH and the capacity of hamster spermatozoa to express hyper activated motility. Gamete Res. 1989;22:163–177
  54. Cote S, Van Sande J, Boeynaems JM. Enhancement of endothelial cAMP accumulation by adeninenucleotides: role of methylxantine-sensitive sites. Am J Physiol. 1993;264:H1498–H1503
  55. Schiffmann Y. An hypothesis: phosphorylation fields as the source of positional information and cell differentiation (cAMP, ATP) as the universal morphogenetic Turing couple. Prog Biophys Mol Biol. 1991;56:79–105
  56. Wyatt TA, Lincoln TM, Pryzwansky KB. Vimentin is transiently co-localized with and phosphorylated by cyclic GMP-dependent protein kinase in formyl-peptide stimulated neutrophils. J Biol Chem. 1991;266:21274–21280
  57. Prieto J, Subira ML, Castillo A. “Opioid Peptides Modulate the Organisation of Vimentin Filaments, Phagocytic Activity and expression of Surface Molecules in Monocytes.”. Scand J Immunol. 1989;29:391–398
  58. Ovadia H, Nitsan P, Abramsky O. Characterisation of opiate binding sites membranes of rat lymphocytes. J Neuroimmunol. 1989;21:93–102
  59. Lavin MF, Watter SD, Song Q. Role of protein kinase in apoptosis. Experientia. 1996;52:979–994
  60. Pryzwansky KB, Merricks EP. Chemotactic peptide-induced changes of intermediate filament organization in neutrophils during granule secretion: role of cyclic guanosine monophosphate. Mol Biol Cell. 1998;9:2933–2947
  61. Pruzanski W, Kennedy BP, Van-den Bosh H, Stefanski E, Vadas P. Microtubule depolymerization selectvely down-regulates the synthesis of proinflammatory secretory nonpancreatic phospholipase A2. Lab Invest. 1997;76:171–178
  62. Herman B, Albertini DF. Microtubule regulation of cell surface receptor topography during granulosa cell differentiation. Differentiation. 1983;25:56–63
  63. Srivastava RK, Srivastava AK, Korsmeyer SJ, Nestrova M, Cho-Chung YS, Longo DL. Involvement of microtubules in the regulation of Bcl-2 phosphorylation and apoptosis through cyclic-AMP dependent protein kinase. Mol Cell Biol. 1998;18:3509–3517
  64. Ito T, Deng X, Carr B, May WS. Bcl-2 phosphorylation required for anti-apoptosis function. J Biol Hem. 1997;272:11671–11673
  65. Wang N, Butler JP, Ingber DE. Mechanotransduction across the cell surface and through the cytoskeleton (see comments). Science. 1993;260:1124–1127
  66. Ingber DE, Dike L, Hansen L, Karp S, Liley H, Maniotis A, et al. Cellular tensegrity: exploring how mechanical changes in the cytoskeleton regulate cell growth, migration, and tissue pattern during morphogenesis. Int Rev Cytol. 1994;150:173–224
  67. Ingber DE. Tensegrity: the architectural basis of cellular mechano-transduction. Annu Rev Physiol. 1997;59:575–599
  68. Pickett-Heaps JD, Forer A, Spruck T. Traction fibre: toward a “tensegral” model of the spindle. Cell Motil Cytoskeleton. 1997;37:1–6
  69. Wang TH, Popp DM, Wang HS, Saitoh M, Mural JG, Henley DC, et al. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c JUN terminal kinase (JNK)-dependent and independent pathways in ovarian cancer cells. J Biol Chem. 1999;274:8208–8216
  70. Pollman MJ, Naumovski L, Gibbons GH. Endothelial cell apoptosis in capillary network remodeling. J Cell Physiol. 1999;178:359–370
  71. Gradin HM, Larsson N, Marklund U, Gullberg M. Regulation of microtubule dynamics by extracellular signals: cAMP-dependent protein kinase switches off the activity of oncoprotein 18 in intact cells. J Cell Biol. 1998;140:131
  72. Maronde E, Middendorff R, Mayer B, Olcese J. The effect of NO donors in bovine and rat pineal cells: stimulation of cGMP and cGMP-independent inhibition of Melatonin synthesis. J Neuroendocrinol. 1995;7:207–214
  73. McCann SM, Kimura M, Karant S, Yu WH, Rettori V. Role of nitric oxide in the neuroendocrine responses to cytokines. Ann N. Y. Acad Sci. 1998;840:174–184
  74. Spessert R, Hill G, Vollrath L. In rat pinealocytes the cyclic GMP response to NO is regulated by Ca2+and Protein Kinase C. Brain Res. 1995;694 (1–2):207–212
  75. Ivanova K, Le-Poole-I C, Gerzer R, Westerhof W, Das PK. Effect of nitric oxide on the adhesion of human melanocytes to extracellular matrix components. J Pathol. 1997;183:469–476
  76. Moriya T, Miyashita Y, Arai J, Kusunoki S, Abe M, Asami K. Light-sensitive response in melanophores of Xenopus laevis: I. Spectral characteristics of melanophore response in isolated tail fin of Xenopus tadpole. J Exp Zool. 1996;276:11–18
  77. D’Acquisto F, Carnuccio R, d’Ischia M, Misuraca G. 5,6-Dihydroxyindole-2-carboxylic acid, a diffusible melanin precursor, is a potent stimulator of lipopolisaccharide-induced production of nitric oxide by J774 macrophages. Life Sci. 1995;57:PL401, PL406
  78. Wilczek A, Mishima Y. Inhibitory effects of melanin monomers, dihydroxyindole-2-carboxylic acid (DHICA) and dihydroxyindole (DHI) on mammalian tyrosinase, with a special reference to the role of DHICA/DHI ratio in melanogenesis. Pigment Cell Res. 1995;8:105–112
  79. Weatherhead B, Logan A. Interaction of alpha-melanocyte stimulating hormone, melatonin, cyclic cAMP and cyclic GMP in the hair follicle melanocytes in vitro. J Endocrinol. 1981;90:89–96
  80. deOliveira AR, Castrucci AM, Visconti M. A. Cellular signalling in vertebrate pigment cells. Braz J Med Biol Res. 1996;29:1743–1749
  81. Okun MR, Donnellan B, Pearson S, Edelstein LE. Melanin: a normal component of human eosinophils. Lab Invest. 1974;30:681–685
  82. Logan A, Weatherhead B. Post-tyrosinase inhibition of melanogenesis by melatonin in hair follicles in vitro. J Invest Dermatol. 1980;74:47–50
  83. Falcon J, Gaildrat P. Variations in cycle adenosino 3′,5′-monophosphate content and efflux from the photosensitive pineal organ of the pike in culture. Pflugers Arch. 1997;433:336–342
  84. Pozo D, Reiter RJ, Calvo JR, Guerrero JM. Physiological concentrations of melatonin inhibit nitric oxide synthase in rat cerebellum. Life Sci. 1994;55:PL455, PL460
  85. Guerrero JM, Pablos MI, Oritz GG, Agapito MT, Reiter RJ. Nocturnal decreases in nitric oxide and cyclic GMP contents in the chick brain and their prevention by light. Neurochem Int. 1996;29:417–421
  86. Sugdan D, Rowe SJ. Protein kinase C activation antagonizes melatonin induced pigment aggregaton in Xenopus laevis melanophores. J Cell Biol. 1992;119:1515–1521
  87. Gilad E, Wong HR, Zingarelli B, Virag L, O’Connor M, Salzman AL, et al. Melatonin inhibits expression of the inducible isoform of nitric oxide synthase in murine macrophages: role of inhibition of NFkappaB activation. FASEB J. 1998;12:685–693
  88. Chuang JI, Mohan N, Meltz ML, Reiter RJ. Effect of melatonin on NF-kappaB DNA-binding activity in the rat spleen. Cell Biol Int. 1996;20:687–692
  89. Grimm S, Bauer MK, Baeuerle PA, Schulze-Osthoff K. Bcl-2 down-regulates the activity of transcription factor NF-kappaB induced apoptosis. J Cell Biol. 1996;134:13–23
  90. Wherle-Haller B, Weston JA. Receptor tyrosine kinase-dependent neural crest migration in response to differentially localized growth factors. Bioassays. 1997;19:337–345
  91. Jockers R, Petit L, Lacroix I, de Coppet P, Barrett P, Morgan PJ, et al. Novel isoforms of Melic melatonin receptors modulating intracellular cyclic guanosine 3′,5′-monophosphate levels. Mol Endocrinol. 1997;11:1070–1081
  92. Wajs E, Kutoh E, Gupta D. Melatonin affects proopiomelanocortin gene expression in the immune organs of the rat. Eur J Endocrinol. 1995;133:754–760
  93. Stepien KB, Dworzanski JP, Bilinska B, Porebska-Budny M, Hollek AM, Wilczok T. Catecholamine melanins. Structural changes induced by copper ions. Biochim Biophys Acta. 1989;997:49–54
  94. Hegedus ZL, Altschule MD. Studies on aminochromes. 3. Transformation of epinephrine, adernochrome and adrenolutininto plasma-soluble melanins during incubation in human blood plasma. Arch Biochem Biophys. 1968;126:388–392
  95. Smythies JR. Oxidative reactions and schizophrenia: a review – discussion. Schizophr Res. 1997;24:357–364
  96. Smythies JR. The biochemical basis of synaptic plasticity and neuro-computation: a new theory. Proc R Soc Lond B Biol Sci. 1997;264:575–579
  97. Smythies JR. On the functional of neuromelanin. Proc R Soc Lond B Biol Sci. 1996;263:487–489
  98. Baez S, Segura-Aguilar J, Widersten M, Johansson AS, Mannervik B. Glutathione transferase catalyse the detoxication of oxidized metabolites (o-quinones) of catecholamines and may serve as an antioxidant system preventing degenerative cellular processes. Biochem J. 1997;324:25–28
  99. Karson CN, Griffin WS, Mrak RE, Husain M, Dawson TM, Snyder SH, et al. Nitric oxide synthase (NOS) in schizophrenia: increases in cerebellar vermis. Mol Chem Neuropathol. 1996;27:275–284
  100. Lin AM, Schaad NC, Schultz PE, Coon SL, Klein DC. Pineal nitric oxide synthase: characteristic, adrenergic regulation and function. Brain Res. 1994;651:160–168
  101. O’Dea RF, Zatz M. Catecholamine-stimulated cyclic AMP accumulation in the rat pineal: apparent presynaptic site in action. Proc Natl Acad Sci USA. 1976;73:3398–3402
  102. Dey SK, Kimura F, Mukherjee F, Dickmann ZJ. Cyclic-AMP and cyclic-GMP in rabbit blastocysts. Reprod Fertil. 1978;52:235–237
  103. Gouge RC, Marshburn P, Gordon BE, Nunley W, Huet-Hudson YM. Nitric oxide as a regulator of embryonic development. Biol Reprod. 1998;58:875–879
  104. Schwab KO, Breitung B, van Stockhausen HB. Inappropriate secretion of umbilical plasma catecholamines in pattern compared to term neonates. J Perinat Med. 1996;24:373–380
  105. Lee QP, Park HW, Thayer J, Mirkes PE, Juchau MR. Apoptosis induced in cultured rat embryos by intra-amniotically microinjected sodium nitroprusside. Teratology. 1996;53:21–30
  106. Jurisicova A, Varmuza S, Casper RF. Programmed cell death and human embryo fragmentation. Mol Hum Reprod. 1996;2:93–98
  107. Kokawa K, Sikone T, Nakano R. Apoptosis in human chorionic villi and decidua during normal embryonic development and spontaneus abortion in the first trimester. Placenta. 1998;19:21–26
  108. Zakeri ZF, Ahuja HS. Cell death/apoptosis: normal, chemically induced, and teratogenic effect. Mutat Res. 1997;396:149–161
  109. Munoz-Hoyos A, Rodriguez-Cabezas T, Molina-Caballo A, Martinez-Sempere JJ, Ruiz-Cosano C, Acuna-Castroviejo D. Melatonin concentration in the umbilical artery and vein human preterm and term neonates with acute fetal distress. J Pineal Res. 1992;13:184–191
  110. Paschke R. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism. Exp Clin Endocrinol Diabetes. 1996;104:129–132
  111. Murakami M, Kamiya Y, Yanagita Y, Koitabashi H, Nagamachi Y, Hosoi Y, et al. Primary culture of cells from hyperfunctioning thyroid adenoma with an activating mutation of G alphas. Mol Cell Endocrinol. 1998;138:137–142
  112. Schwab KO, Sohlemann P, Gerlich M, Broecker M, Petrykowski W, Holzapfel HP, et al. Mutation of the TSH receptor as cause of congenital hyperthyroidism. Exp Clin Endocrinol Diabetes. 1996;104:124–128
  113. Dawson VL, Dawson TM. Nitric oxide neurotoxity. J Chem Neuroanat. 1996;10:179–190
  114. Molina JA, Jimenez-Jimenez FJ, Orti-Pareja M, Navarro JA. The role of nitric oxide in neurodegeneration. Potential for pharmacological intervention. Drugs Aging. 1998;12:251–259
  115. Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ, et al. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer’s disease. Brain Res Rev. 1997;23:47–61
  116. Wink DA, Vodovotz Y, Laval F, Laval J, Dewhirst MW, Mitchell JB. The multifaceted roles of nitric oxide in cancer. Carcinogenesis. 1998;19:711–721
  117. Qui HY, Henrion D, Benessiano J, Heymes C, Tournier B, Levy BI. Decreased flow-induced dilation and increased production of cGMP in spontaneously hypertensive rats. Hypertension. 1998;32:1098–1103
  118. Lahera V, Salazar J, Salom MG, Romero JC. Deficient production of nitric oxide induces volume-dependent hypertension. J Hypertens Suppl. 1992;10:S173–177
  119. Inoue T, Fukuo K, Nakahashi T, Hata S, Morimoto S, Ogihara T. cGMP upregulates nitric oxide synthase expression in vascular smooth muscle cells. Hypertension. 1995;25:711
  120. Etgen GJ, Fryburg DA, Gibbs EM. Nitric oxide stimulates skeletal muscle glucose transport through a calcium/concentration- and phosphatidylinositol-3-kinase-independent pathway. Diabetes. 1997;46:1915–1919
  121. Contraras R, Fuentes O, Mann GE, Sobrevia L. Diabetes and insulin-induced stimulation of L-arginine transport and nitric oxide synthesis in rabbit isolated gastric glands. J Physiol Lond. 1997;498:787–796
  122. Champney TH, Brainard GC, Richardson BA, Reiter R. Experimentally-induced diabetes reduces nocturnal pineal melatonin content in the Syrian hamster. Comp Biochem Physiol A. 1983;76:199–220
  123. Dinarello CA, Wolff MS. The role of interleukin-1 in disease. N Engl J Med. 1993;328:106–113
  124. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood. 1991;77:1621–1652
  125. Bell DR, Dec EM, Rensberger HJ. Selective effect of high arterial pressure in hypertension upon inhibition of cGMP versus cAMP mediated vascular relaxation. Clin Exp Hypertens. 1996;18:773–791
  126. Akama KT, Albanese C, Pastell RG, Van-Eldik LJ. Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism. Proc Natl Acad Sci USA. 1998;95:5795–5800
  127. Reiter RJ. Functional pleiotropy of the neurohormone melatonin: antioxidant protection and neuroendocrine regulation. Front Neuroendocrinol. 1995;16:383–415
  128. DeRubertis FR, Chayoth R, Field JB. The content and metabolism of cyclic adenosine 3′,5′-monophosphate and cyclic guanosine 3′,5′-monophosphate in adenocarcinoma of the human colon. J Clin Invest. 1976;57:641–649
  129. Heinonen PK, Metsa-Ketela T. Prostanoids and cyclic nucleotides in malignant and benign ovarian tumors. Med Oncol Tumor Pharmacother. 1988;5:11–15
  130. Maiolo AT, Baldini L, Polli EE. Plasma and urine cyclic nucleotide levels in patients with neoplastic diseases. Cancer. 1984;54:3028–3034
  131. Pearse AG. The APUD concept and hormone production. Clin Endocrinol Metab. 1980;9:211–222
  132. Imura H. Ectopic hormone syndromes. Clin Endocrinol Metab. 1980;9:235–260
  133. Imura H, Nakai Y, Takahashi H. Hormone production and abnormalities in gene expression in tumors. Gan To Kagaku Ryoho. 1986;13:721–730
  134. Mbikay M, Seidah NG, Chretien M. From proopiomelanocortin to cancer. Possible role of convertases in neoplasm. Ann NY Acad Sci. 1993;680:13–19
  135. Wajchenberg, B. L. Mendonca, B. Liberman, B. Adelaide, M. Pereira, A. Kirschner, M. A. Ectopic ACTH syndrome (published erratum appears, J. Steroid Biochem Mol Biol, 1995, 54, 287, J. Steroid Biochem Mol Biol, 1995, 53, 139, 151
  136. Scopsi L, Balslev E, Brunner N, Poulsen HS, Andersen J, Rank F, et al. Immunoreactive opioid peptides in human breast cancer. Am J Pathol. 1989;134:473–479
  137. Pasi A, Amsler U, Messiha FS. Beta-endorphin-like immunoreactivity: assesment of blood levels in patients with tumors of different origin. J Med. 1991;22:327–337
  138. Lunec J, Pieron C, Sherbert GV, Thody AJ. Alpha-melanocyte-stimulating hormone immunoreactivity in melanoma cells. Pathobiology. 1990;58:193–197
  139. Bakshi A, Nag TC, Wadhwa S, Mahapatra AK, Sarkar C. The expression of nitric oxide synthases in human brain tumours and peritumoral areas. J Neurol Sci. 1998;155:196–203
  140. Li QF, Wang DY. The differentiation of human gastric adenocarcinoma cell line MGc-80-3 induced by dibutryl cAMP in vitro. Shih Yen Sheng Wu Hsueh Pao. 1990;23:167–175
  141. Bershtein LM. Dynamics of urinary excretion of cyclic nucleotides in cancer patients during a long-term follow-up. Vopr Onkol. 1987;33:54–58
  142. Israeli E, Raz B, Kerner H, Barzilai D. Cyclic nucleotide levels in breast cancer and in rat mammary tissues during tumor development. Breast Cancer Res Treat. 1985;6:241–248
  143. Peracchi M, Toschi V, Bamonti-Catena F, Lombardi L, Bareggi B, Cortelezzi A, et al. Plasma cyclic nucleotide levels in acute leukemia patients. Blood. 1987;69:1613–1616
  144. Chen TC, Hinton DR, Zidovetzki R, Hofman FM. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. Lab Invest. 1998;78:165–174
  145. Lanotte M, Riviere JB, Hermouet S, Houge G, Vintermyr OK, Gjertsen BT, et al. Programmed cell death (apoptosis) is induced rapidly and with positive cooperativity by activation of cyclic adenosine monophosphate – Kinase I in a myeloid leukemia cell line. J Cell Physiol. 1991;146:73–80
  146. Busse E, Baum RP, Hor G, Kornhuber B. In vitro and in vivo effect of thyroid hormones on the growth of neuroblastoma cells. II. The effect of thyroxine in vivo. Nuclearmedizin. 1990;29:125–128
  147. Jun CD, Pae HO, Yo JC, Kwak HJ, Park RK, Chung HT. Cyclic adenosine monophosphate inhibits nitric oxide-induced apoptosis in human leukemic HL-60 cells. Cell Immunol. 1998;183:13–21
  148. Schubert P, Ogata T, Rudophi K, Marchini C, McRae A, Ferroni S. Support of homeostatic glial signalling: a novel therapeutic approach by propentofylline. Ann NY Acad Sci. 1997;826:337–347
  149. Schubert P, Ogata T, Ferroni S, McRae A, Nakamura Y, Rudophi K. Modulation of glial cells signaling by adenosine and pharmacological reinforcement. A neuroprotective strategy?. Mol Chem Neuropathol. 1996;28:185–190
  150. Vintermyr OK, Boe R, Brustungun OT, Maronde E, Aakvaag A, Doskeland SO. Cyclic adenosine monophosphate (cAMP) analogs 8-Cl and 8-NH2-cAMP induce cell death independently of cAMP kinase mediated inhibition of the G1/S transition in mammary carcinoma cells. Endocrinology. 1995;136:2513–2520
  151. Roth JA, Rabin R, Agnello K. Melatonin suppression of PC12 cell growth and death. Brain Res. 1997;768:63–70
  152. Farinelli SE, Park DS, Greene LA. Nitric oxide delays the death of tropic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanism. J Neurosci. 1996;16:2325–2334
  153. Wei JY, Cohen ED, Genieser HG, Barnstable CJ. Substituted cGMP analogs can act as elective agonists of the rod photoreceptor cGMP-gated cation channel. J Mol Neurosci. 1998;10:53–64
  154. Mochizuki H, Mori H, Mizumo Y. Apoptosis in neurodegenerative disorders. J Neural Transm Suppl. 1997;50:125–140
  155. Cattaneo G, Fraschini F. Melatonin increase as predictor for tumor objective response to chemotherapy in advanced cancer patients. Tumori. 1988;74:339–345

PII: S0306-9877(00)91137-X

doi: 10.1054/mehy.2000.1137

Medical Hypotheses
Volume 56, Issue 2 , Pages 181-193 , February 2001

Article Tools